Marhold, Maximilian http://orcid.org/0000-0001-8439-3312
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 10 October 2021
Accepted: 18 November 2021
First Online: 23 December 2021
Conflict of interest
: M. Marhold has received honoraria for lectures, advisory board participation and consultation from Roche, Eli Lilly, Novartis, AstraZeneca, Daiichi Sankyo, Pfizer and Medmedia and travel support from Amgen, Roche, Novartis, Pierre Fabre, Daiichi Sankyo, Pfizer and Eisai.